Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid

Clinica Chimica Acta

Volumn 248, Issue 2, 1996, Pages 175-185

  Fracchia, Mario ^a   Setchell, Kenneth D R ^b   Crosignani, Andrea ^c   Podda, Mauro ^c   O'Connell, Nancy ^b   Ferraris, Roberto ^a   Hofmann, Alan F ^d   Galatola, Giovanni ^a  

^a MAURIZIANO HOSPITAL   (Italy)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bile acid conjugation efficiency; cholehepatic shunting; cholestasis; primary biliary cirrhosis; primary sclerosing cholangitis; unconjugated bile acids; ursodeoxycholic acid

Indexed keywords

BILE ACID CONJUGATE; LIDOFENIN TC 99M; URSODEOXYCHOLIC ACID;

ARTICLE; BILE COMPOSITION; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER DISEASE; MASS SPECTROMETRY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030003493     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06252-1     Document Type: Article

References (34)

1. Simko V, Michael S, Prego V. Ursodeoxycholic therapy in chronic liver disease: a metaanalysis in primary biliary cirrhosis and in chronic hepatitis. Am J Gastroenterol 1994;89:392-398.
2. Leuschner U. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Scand J Gastroenterol 1994;29(204):40-46.
3. Kitani K. Hepatoprotective effect of ursodeoxycholate in experimental animals. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer, 1990;43-56.
4. Heuman D, Mills A, McCall J, Hylemon P, Pandak W, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology 1991;100:203-211.
5. Jazrawi RP, de Caestecker JS, Goggin PM, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106:134-142.
6. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990;11:12-15.
7. Lacaille F and Paradis K. Immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993;18:165-172.
8. Erlinger S, Dumont M. Influence of ursodeoxycholic acid on bile secretion. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic, 1990:35-42.
9. Gilmore IT, Barnhart JL, Hofmann AF, Erlinger S. Effects of individual taurine-conjugated bile acids on biliary secretion and sucrose clearance in the unanesthetized dog. Am J Physiol 1982;5:G40-G46.
10. Gurantz D, Hofmann AF. Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster. Am J Physiol 1984;247:G736-G748.
11. Kitani K, Kanai S, Ohta M, Sato Y. Differing transport maxima values for taurine-conjugated bile salts in rats and hamsters. Am J Physiol 1986;251:G852-G858.
12. Yoon YB, Hagey LR, Hofmann AF, Gurantz D, Michelotti EL, Steinbach JH. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology 1986;90:837-852.
13. Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocolic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980;79:82-89.
14. Kitani K, Kanai S. Ursodeoxycholate-induced choleresis in taurine-deprived and taurine-supplemented rats. Jpn J Physiol 1985;35:443-462.
15. Erlinger S. Hypercholeretic bile acids: a clue to the mechanism? Hepatology 1990;11:888-890.
16. Hofmann AF. The cholehepatic circulation of unconjugated bile acids: an update. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile acids and the hepatobiliary system. Boston: Kluwer Academic Publishers 1993;143-160.
17. Matoba N, Une M, Hoshita T. Identification of unconjugated bile acids in human bile. J Lipid Res 1986;27:1154-1162.
18. Batta AK, Salen G, Mirchandanir et al. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis. Am J Gastroenterol 1993;88:691-700.
19. Hofmann AF. Enterohepatic circulation of bile acids. In: Schultz SG, ed. Handbook of physiology. Section on the Gastrointestinal System. Bethesda: American Physiological Society, 1989;567-596.
20. Hepner GW, Hofmann AF, Thomas PJ. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. II. Glycine-conjugated dihydroxy bile acids. J Clin Invest 1972;51:1898-1905.
21. Fracchia M, Ferraris R, Petrarulo M, Secreto P, Dunn T, Galatola G. Effect of ursodeoxycholic acid on the masses of biliary lipids and alkaline phosphatase within the gallbladder in chronic cholestatic liver disease. Eur J Gastroenterol Hepatol 1992:4:843-848.
22. Schaffner F, Popper H. Clinical-pathologic relations in primary biliary cirrhosis. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol 7. New York: Grune and Stratton, 1982;529-545.
23. Jazrawi RP, Galatola G, Lanzini A, Northfield TC. Biliary lipid mass within the gallbladder in health and in cholesterol gallstone disease. Eur J Gastroenterol Hepatol 1993;5:373-381.
24. Lawson AM, Setchell KDR. Mass spectrometry of bile acids. In: KDR Setchell, Kritchevsky D and Nair PP, eds. The bile acids: chemistry, physiology and metabolism. Vol. 4: Methods and applications. New York and London, Plenum Press, 1988:167-267.
25. Nakayama F, Nakagaki M. Quantitative determination of bile acids in bile with reversed-phase high performance liquid chromatography. J Chromatogr 1980;105:407-410.
26. Crosignani A, Podda M, Battezzati PM et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration Hepatology 1991;14:1000-1007.
27. Borgstrom B, Barrowman J, Krabisch L, Lindstrom M, Lillienau J. Effects of cholic acid, 7 beta-hydroxy-and 12 beta-hydroxy-isocholic acid on bile flow, lipid secretion and bile acid synthesis in the rat. Scand J Clin Lab Invest 1986;46:167-175.
28. Lillienau J, Hagey LR, Borgstrom B. Hepatic and ileal transport and effect on biliary secretion of norursocholic acid and its conjugates in rats. Am J Physiol 1991;261: G1057-G1064.
29. + exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated ursodeoxycholate, and increased ursodeoxycholate glucuronidation. Gastroenterology 1988;95:454-463.
30. Festi D, Fraboni R, Bazzoli F et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990;99:1779-1785.
31. Van Erpekum KJ, van Berge Henegouwen GP, Stolk MF, Hopman WP, Jansen JB and Lamers CB. Fasting gallbladder volume, postprandial emptying, and cholecystokinin release in gallstone patients and normal subjects. J Hepatol 1992;14:194-202.
32. Knyrim K, Vakil N, Pfab R, Classen M. The effects of intraduodenal bile acid administration on biliary secretion of ionized calcium and carbonate in man. Hepatology 1989;10:134-142.
33. Loria P, Carulli N, Medici G et al. Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion. Gastroenterology 1989;96:1142-1150.
34. Zakko S, Lira M, Clerici C et al. Novel metabolism and hypercholeretic effect of norursodeoxycholic acid in man (Abstr). Gastroenterology 1987;92:1793.